Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...

Hyperscaler cloud is inherently global. Does that make data sovereignty unattainable – especially given the powers US courts ...

Good afternoon, everyone, and welcome to IonQ's First Quarter 2026 Earnings Call. My name is Hanley Donofrio, and I am the Investor Relations Director here at IonQ. I'm pleased to be joined on today's ...

As a result of the organizational changes associated with Match Group Asia that Spencer discussed, beginning with our Q2 2026 results, we will combine the Match Group Asia and E&E business units into ...

What once belonged purely to science fiction is steadily becoming part of everyday life. From automation to advanced tech ...